Cargando…

The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital

BACKGROUND: The prescriptions of proton pump inhibitors (PPIs) have raised concern due to both huge increase in medical expenditure and the possible long-term adverse events caused by them; therefore, an approach to taper off the irrational use of PPIs by patients is clinically warranted. The aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Chuanwei, Dong, Zhu, Lin, Mengmeng, Li, Gong-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749561/
https://www.ncbi.nlm.nih.gov/pubmed/29343945
http://dx.doi.org/10.2147/PPA.S150388
_version_ 1783289604688838656
author Xin, Chuanwei
Dong, Zhu
Lin, Mengmeng
Li, Gong-Hua
author_facet Xin, Chuanwei
Dong, Zhu
Lin, Mengmeng
Li, Gong-Hua
author_sort Xin, Chuanwei
collection PubMed
description BACKGROUND: The prescriptions of proton pump inhibitors (PPIs) have raised concern due to both huge increase in medical expenditure and the possible long-term adverse events caused by them; therefore, an approach to taper off the irrational use of PPIs by patients is clinically warranted. The aim of this study was to evaluate the impact of pharmaceutical interventions on the rational use of PPIs. PATIENTS AND METHODS: A single-center, pre- to post-intervention study (pharmaceutical interventions group and control group) was performed in a Chinese hospital. Pharmaceutical interventions were performed in the post-intervention group, including educative group activities, real-time monitoring of clinical records and making recommendations to doctors on PPI prescriptions based on the criteria set at the beginning of the study. The number of patients with rational indication, the accuracy rate of administration route, the duration of therapy and the changes in total PPI costs, mean PPI costs, mean total drug costs and mean hospitalization costs were the main outcome measures. RESULTS: A total of 285 patients were included in the study. After 6 months of interventions, significant improvements in the number of patients with rational indication were found (96.5% in the pharmaceutical interventions group vs 71.8% in the control group, P<0.01). The accuracy rate of administration route was increased (99.3% vs 73.2%, P<0.05), while the duration of therapy was decreased (7.9±0.5 vs 14.3±0.8, P<0.01). Pharmaceutical interventions led to significant reductions in mean PPIs costs, mean total drug costs and mean hospitalization costs (P<0.001). CONCLUSION: This study provides important evidence on the beneficial effect of pharmaceutical interventions on enhancing the rational use of PPIs and substantial cost saving by increasing the number of patients with rational indication and reducing the risk for long-term adverse events.
format Online
Article
Text
id pubmed-5749561
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-57495612018-01-17 The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital Xin, Chuanwei Dong, Zhu Lin, Mengmeng Li, Gong-Hua Patient Prefer Adherence Original Research BACKGROUND: The prescriptions of proton pump inhibitors (PPIs) have raised concern due to both huge increase in medical expenditure and the possible long-term adverse events caused by them; therefore, an approach to taper off the irrational use of PPIs by patients is clinically warranted. The aim of this study was to evaluate the impact of pharmaceutical interventions on the rational use of PPIs. PATIENTS AND METHODS: A single-center, pre- to post-intervention study (pharmaceutical interventions group and control group) was performed in a Chinese hospital. Pharmaceutical interventions were performed in the post-intervention group, including educative group activities, real-time monitoring of clinical records and making recommendations to doctors on PPI prescriptions based on the criteria set at the beginning of the study. The number of patients with rational indication, the accuracy rate of administration route, the duration of therapy and the changes in total PPI costs, mean PPI costs, mean total drug costs and mean hospitalization costs were the main outcome measures. RESULTS: A total of 285 patients were included in the study. After 6 months of interventions, significant improvements in the number of patients with rational indication were found (96.5% in the pharmaceutical interventions group vs 71.8% in the control group, P<0.01). The accuracy rate of administration route was increased (99.3% vs 73.2%, P<0.05), while the duration of therapy was decreased (7.9±0.5 vs 14.3±0.8, P<0.01). Pharmaceutical interventions led to significant reductions in mean PPIs costs, mean total drug costs and mean hospitalization costs (P<0.001). CONCLUSION: This study provides important evidence on the beneficial effect of pharmaceutical interventions on enhancing the rational use of PPIs and substantial cost saving by increasing the number of patients with rational indication and reducing the risk for long-term adverse events. Dove Medical Press 2017-12-27 /pmc/articles/PMC5749561/ /pubmed/29343945 http://dx.doi.org/10.2147/PPA.S150388 Text en © 2018 Xin et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Xin, Chuanwei
Dong, Zhu
Lin, Mengmeng
Li, Gong-Hua
The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title_full The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title_fullStr The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title_full_unstemmed The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title_short The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a Chinese hospital
title_sort impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a chinese hospital
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749561/
https://www.ncbi.nlm.nih.gov/pubmed/29343945
http://dx.doi.org/10.2147/PPA.S150388
work_keys_str_mv AT xinchuanwei theimpactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT dongzhu theimpactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT linmengmeng theimpactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT ligonghua theimpactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT xinchuanwei impactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT dongzhu impactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT linmengmeng impactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital
AT ligonghua impactofpharmaceuticalinterventionsontherationaluseofprotonpumpinhibitorsinachinesehospital